Patient age, years mean (range) | 47 (17–66) |
---|---|
Donor age, years mean (range) | 45 (11–68) |
Diagnosis, frequency | |
Acute myeloid leukaemia | 77 |
Multiple myeloma | 54 |
Acute lymphoid leukaemia | 48 |
Chronic lymphoid leukaemia | 45 |
Myelodysplastic syndrome | 23 |
Chronic myeloid leukaemia | 13 |
Non-Hodgkin lymphoma | 13 |
Other | 36 |
Disease status | |
Good prognosis | 148 |
Bad prognosis | 142 |
Gender, patient-donor | |
male-male | 82 |
male-female | 67 |
female-male | 76 |
female-female | 63 |
Graft origin | |
Peripheral blood | 128 |
Bone marrow | 162 |
Conditioning | |
Myeloablative | 233 |
Other | 57 |
GvHD prevention | |
Cyclosporine, Methotrexate and Methylprednisolone | 207 |
Cyclosporine and Mycophenolate Mofetil | 46 |
Cyclosporine and Methotrexate | 37 |
Acute GvHD | |
No | 197 |
grade III–IV | 29 |
Chronic GvHD | |
No | 117 |
Extensive | 72 |